John R. Moore - General Counsel at Edgewise Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Stock Symbol
EWTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

John R. Moore - trading volume in the past year for Edgewise Therapeutics, Inc.

Holdings reported by John R. Moore for Edgewise Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 26.9K $437K $18.91 Aug 12, 2025 Direct Common Stock
Common Stock 10.2K $137K $13.39 Aug 12, 2025 Direct
Stock Option (Right to Buy) 161K Aug 12, 2025 Direct Common Stock

Transactions reported by John R. Moore for Edgewise Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.